Portfolio News

An inside look at a national, bilingual telemedicine service

Galileo is a telehealth service that delivers 24/7 primary and specialty care in both English and Spanish. It operates across all 50 U.S. states and enjoys support from regional and national health plans, Fortune 500 organizations, and employers of a variety of sizes. The fact that Galileo offers fully bilingual services removes a major barrier to healthcare access for the 53 million Spanish speakers in the U.S. In a recent interview, Galileo Clinical Systems Leader Dr. Jason Chirichigno discussed how a nationwide telemedicine platform works and...

The Top 100 Healthcare Technology Companies of 2022

Augmedix has made the Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2022. “The awardees on this year’s list represent the absolute best in the healthcare technology space,” the Healthcare Technology Report wrote. “These companies are changing the face of the industry.” What all the awardees have in common is that they are leveraging their talent to find innovative solutions to healthcare’s most pressing issues. In the process, they are saving lives and extending healthspans. This year’s top 100 companies represent a range of specialties, from genomics...

AllyAlign, Partners Form Curana Health to Expand Value-Based Care in Senior Living

As value-based care continues to expand at a rapid pace within senior living, AllyAlign Health has announced a partnership with two different health care organizations. The partnership forms Curana Health, with the intention of helping skilled nursing and senior living facilities across the U.S. The three companies, AllyAlign Health, Provider Health Services, and Elite Patient Care, are expecting the bid to encourage growth for the future of value-based health care service models. AllyAlign Health’s goal is to improve service at skilled nursing and senior living providers...

Synthetic data trailblazer and CHEO Research Institute spin-off, Replica Analytics, acquired by Aetion signalling CHEO as a place for incubating start-ups

Synthetic data generation startup Replica Analytics was recently acquired by real world evidence technology company Aetion. Replica was first founded by members of the CHEO Research Institute and the University of Ottawa Faculty of Medicine. This acquisition demonstrates how academic research can be put into practice faster with the help of commercialization. Replica was co-founded in 2019 by Dr. Khaled El Emam, head of the CHEO Research Institute’s Electronic Health Information Laboratory. His position involves conducting research and developing technology, like generating synthetic data. The goal...

FDA Biomarker—John Wagner

Koneksa Health Chief Medical Officer John A. Wagner, MD, Ph.D., recently gave a video presentation titled “Multi-Component Biomarkers: Promise, Practice and Perspective on Terminology,” which was uploaded to the U.S. Food and Drug Administration’s YouTube channel. Dr. Wagner began with a general introduction to biomarkers. A biomarker is a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention, including therapeutic interventions. Some biomarkers that will be familiar even to people without a strong...